1,2-dimethylhydrazine multiple interactions ISO RGD:1311983 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of RGMA mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of RGMA mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO RGD:1311983 6480464 1-Naphthylisothiocyanate results in increased expression of RGMA mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGMA mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of RGMA mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1323724 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of RGMA mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGMA mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1311983 6480464 Tetrachlorodibenzodioxin results in decreased expression of RGMA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323724 6480464 Tetrachlorodibenzodioxin affects the expression of RGMA mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RGMA mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1311983 6480464 2 more ... CTD PMID:32109520 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of RGMA mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1323724 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RGMA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RGMA mRNA CTD PMID:28628672 acrylamide decreases expression ISO RGD:1311983 6480464 Acrylamide results in decreased expression of RGMA mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1323724 6480464 Acrylamide results in decreased expression of RGMA mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1323724 6480464 Aflatoxin B1 results in increased expression of RGMA mRNA CTD PMID:21641981 aflatoxin B1 increases methylation ISO RGD:1323724 6480464 Aflatoxin B1 results in increased methylation of RGMA 3' UTR more ... CTD PMID:27153756 , PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1323724 6480464 Tretinoin results in decreased expression of RGMA mRNA CTD PMID:21934132 , PMID:23724009 aristolochic acid A increases expression ISO RGD:1323724 6480464 aristolochic acid I results in increased expression of RGMA mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1323724 6480464 Arsenic affects the methylation of RGMA gene CTD PMID:25304211 arsane multiple interactions ISO RGD:1323724 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RGMA mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1323724 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RGMA mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:1323724 6480464 Arsenic affects the methylation of RGMA gene CTD PMID:25304211 atrazine increases expression ISO RGD:1323724 6480464 Atrazine results in increased expression of RGMA mRNA CTD PMID:22378314 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RGMA mRNA] CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1323724 6480464 Benzo(a)pyrene results in increased expression of RGMA mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1323724 6480464 Benzo(a)pyrene affects the methylation of RGMA intron, Benzo(a)pyrene affects the methylation of RGMA promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1323724 6480464 Benzo(a)pyrene results in increased methylation of RGMA 3' UTR, Benzo(a)pyrene results in increased methylation of RGMA exon CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of RGMA mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1323724 6480464 Diethylhexyl Phthalate results in decreased expression of RGMA mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1311983 6480464 bisphenol A affects the expression of RGMA mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RGMA mRNA CTD PMID:32156529 , PMID:34585602 bisphenol A increases methylation ISO RGD:1311983 6480464 bisphenol A results in increased methylation of RGMA gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1323724 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RGMA mRNA CTD PMID:28628672 bisphenol A increases expression ISO RGD:1311983 6480464 bisphenol A results in increased expression of RGMA mRNA CTD PMID:30816183 bisphenol A decreases expression ISO RGD:1323724 6480464 bisphenol A results in decreased expression of RGMA mRNA CTD PMID:27685785 bisphenol F multiple interactions ISO RGD:1323724 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RGMA mRNA CTD PMID:28628672 bromobenzene increases expression ISO RGD:1311983 6480464 bromobenzene results in increased expression of RGMA mRNA CTD PMID:32479839 butanal increases expression ISO RGD:1323724 6480464 butyraldehyde results in increased expression of RGMA mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1323724 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RGMA mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1323724 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RGMA mRNA CTD PMID:35301059 carbamazepine affects expression ISO RGD:1323724 6480464 Carbamazepine affects the expression of RGMA mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO RGD:1323724 6480464 CGP 52608 promotes the reaction [RORA protein binds to RGMA gene] CTD PMID:28238834 cisplatin multiple interactions ISO RGD:1323724 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of RGMA mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1323724 6480464 Cisplatin results in increased expression of RGMA mRNA CTD PMID:27392435 Cuprizon increases expression ISO RGD:1311983 6480464 Cuprizone results in increased expression of RGMA mRNA CTD PMID:26577399 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of RGMA mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1323724 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RGMA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RGMA mRNA CTD PMID:28628672 dorsomorphin multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1323724 6480464 Doxorubicin results in increased expression of RGMA mRNA CTD PMID:30031762 endosulfan decreases expression ISO RGD:1311983 6480464 Endosulfan results in decreased expression of RGMA mRNA CTD PMID:29391264 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of RGMA mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of RGMA mRNA CTD PMID:30319688 folic acid decreases expression ISO RGD:1323724 6480464 Folic Acid results in decreased expression of RGMA mRNA CTD PMID:21867686 fulvestrant increases methylation ISO RGD:1323724 6480464 Fulvestrant results in increased methylation of RGMA gene CTD PMID:31601247 gentamycin decreases expression ISO RGD:1311983 6480464 Gentamicins results in decreased expression of RGMA mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:1323724 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RGMA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RGMA mRNA CTD PMID:28628672 Licochalcone B increases expression ISO RGD:1323724 6480464 licochalcone B results in increased expression of RGMA mRNA CTD PMID:33647349 mercury dibromide decreases expression ISO RGD:1323724 6480464 mercuric bromide results in decreased expression of RGMA mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA CTD PMID:27188386 methylmercury chloride decreases expression ISO RGD:1323724 6480464 methylmercuric chloride results in decreased expression of RGMA mRNA CTD PMID:28001369 methylphenidate decreases expression EXP 6480464 Methylphenidate results in decreased expression of RGMA mRNA CTD PMID:22470460 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of RGMA mRNA CTD PMID:25566086 p-chloromercuribenzoic acid decreases expression ISO RGD:1323724 6480464 p-Chloromercuribenzoic Acid results in decreased expression of RGMA mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1323724 6480464 panobinostat results in decreased expression of RGMA mRNA CTD PMID:26272509 paraquat decreases expression ISO RGD:1311983 6480464 Paraquat results in decreased expression of RGMA mRNA CTD PMID:32680482 PCB138 decreases expression ISO RGD:1311983 6480464 2 more ... CTD PMID:23829299 phenylmercury acetate decreases expression ISO RGD:1323724 6480464 Phenylmercuric Acetate results in decreased expression of RGMA mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA CTD PMID:27188386 propanal increases expression ISO RGD:1323724 6480464 propionaldehyde results in increased expression of RGMA mRNA CTD PMID:26079696 SB 431542 multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1323724 6480464 Silicon Dioxide analog results in decreased expression of RGMA mRNA CTD PMID:25895662 silver atom decreases expression EXP 6480464 Silver results in decreased expression of RGMA mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of RGMA mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:1323724 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RGMA mRNA CTD PMID:32525701 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of RGMA mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:1311983 6480464 Carbon Tetrachloride results in decreased expression of RGMA mRNA CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1323724 6480464 Thapsigargin results in decreased expression of RGMA mRNA CTD PMID:29453283 trichloroethene increases expression ISO RGD:1311983 6480464 Trichloroethylene results in increased expression of RGMA mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1323724 6480464 trichostatin A results in decreased expression of RGMA mRNA CTD PMID:22723015 more ... trichostatin A multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA CTD PMID:27188386 triclosan increases methylation ISO RGD:1323724 6480464 Triclosan results in increased methylation of RGMA gene CTD PMID:34523531 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of RGMA mRNA CTD PMID:19042947 urethane increases expression ISO RGD:1323724 6480464 Urethane results in increased expression of RGMA mRNA CTD PMID:28818685 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of RGMA mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1323724 6480464 Valproic Acid results in decreased expression of RGMA mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1323724 6480464 Valproic Acid results in decreased methylation of RGMA gene CTD PMID:29154799 vorinostat multiple interactions ISO RGD:1323724 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:1323724 6480464 vorinostat results in decreased expression of RGMA mRNA CTD PMID:26272509 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of RGMA mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO RGD:1311983 6480464 squalestatin 1 results in decreased expression of RGMA mRNA CTD PMID:27225895